Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
177M
-
Number of holders
-
73
-
Total 13F shares, excl. options
-
18.3M
-
Shares change
-
+2.16M
-
Total reported value, excl. options
-
$170M
-
Value change
-
+$20.3M
-
Put/Call ratio
-
0.48
-
Number of buys
-
40
-
Number of sells
-
-28
-
Price
-
$9.28
Significant Holders of OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) as of Q1 2017
90 filings reported holding OCUL - OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share as of Q1 2017.
OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) has 73 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.3M shares
of 177M outstanding shares and own 10.37% of the company stock.
Largest 10 shareholders include JENNISON ASSOCIATES LLC (3.22M shares), Versant Venture Management, LLC (2.22M shares), SV Health Investors, LLC (1.61M shares), FMR LLC (1.37M shares), WELLINGTON MANAGEMENT GROUP LLP (1.31M shares), BlackRock Inc. (1.29M shares), COLUMBUS CIRCLE INVESTORS (1.09M shares), VANGUARD GROUP INC (902K shares), MORGAN STANLEY (605K shares), and Opaleye Management Inc. (550K shares).
This table shows the top 73 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.